IF 2.2 3区医学

Angiology Pub Date : 2025-10-01 Epub Date: 2023-08-16 DOI: 10.1177/00033197231196948

引用次数: 0

Impact of Contrast-Associated Acute Kidney Injury on One-Year Outcomes in Very Elderly STEMI Patients: Insights From a Multicenter Registry in Northern Italy. 对比度相关急性肾损伤对高龄 STEMI 患者一年预后的影响：意大利北部多中心登记的启示。

IF 2.2 3区医学

Angiology Pub Date : 2025-10-01 Epub Date: 2024-02-20 DOI: 10.1177/00033197241233771

Alessandro Ruzzarin, Simone Muraglia, Enrico Fabris, Giorgio Caretta, Filippo Zilio, Andrea Pezzato, Gianluca Campo, Matthias Unterhuber, Luca Donazzan

{"title":"Impact of Contrast-Associated Acute Kidney Injury on One-Year Outcomes in Very Elderly STEMI Patients: Insights From a Multicenter Registry in Northern Italy.","authors":"Alessandro Ruzzarin, Simone Muraglia, Enrico Fabris, Giorgio Caretta, Filippo Zilio, Andrea Pezzato, Gianluca Campo, Matthias Unterhuber, Luca Donazzan","doi":"10.1177/00033197241233771","DOIUrl":"10.1177/00033197241233771","url":null,"abstract":"Data about contrast-associated acute kidney injury (CA-AKI) in oldest old (age ≥85 years) ST-elevation myocardial infarction (STEMI) patients are scarce. We evaluated the incidence and the 1-year prognostic impact of CA-AKI in this population. Patients were included in a multicenter real-world registry, and CA-AKI was defined according to KDIGO (Kidney Disease Improving Global Outcomes) criteria. Major adverse cardiac and cerebrovascular events (MACCEs) were defined as the composite of all-cause death, stroke, unplanned coronary revascularization, and heart failure hospitalization. The primary outcome was the incidence and impact of CA-AKI on MACCEs at 1 year follow-up. Out of 461 STEMI patients (mean age 88.6 ± 2.9 years), 102 (22.1%) patients developed CA-AKI. Chronic kidney disease was the strongest predictor of CA-AKI (odds ratio [OR]: 4.52, 95% CI: 2.81-7.30, P < .01). The CA-AKI cohort showed a higher risk of MACCEs (adjusted HR: 1.75, 95% CI: 1.13-2.71, P = .01), driven mainly by all-cause death (adjusted hazard ratio [HR]: 2.39, 95% CI: 1.41-4.07, P = .01) and followed by heart failure hospitalization (adjusted HR: 2.01, 95% CI: 1.08-3.76, P = .01). Among oldest old STEMI, CA-AKI was frequent and associated with a higher incidence of MACCEs at 1-year follow-up.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"886-893"},"PeriodicalIF":2.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139911877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reply Letter to: Carotid Artery Stenosis as a Predictor for Stroke Following Transcatheter Aortic Valve Implantation. 回信：颈动脉狭窄是经导管主动脉瓣植入术后脑卒中的预测因素。

IF 2.2 3区医学

Angiology Pub Date : 2025-10-01 Epub Date: 2024-07-23 DOI: 10.1177/00033197241265252

Atsushi Sugiura, Leonard Taube, Arthur Hartmann, Christian Schaefer, Marwan Hamiko, Sebastian Zimmer, Georg Nickenig, Nadjib Schahab

引用次数: 0

12-Month Outcomes of Carotid Artery Stenting With CGuard MicroNET-Covered Stent: A Single-Center Study in 113 Patients. 颈动脉支架应用CGuard MicroNET覆盖支架12个月的疗效：113例患者的单中心研究。

IF 2.2 3区医学

Angiology Pub Date : 2025-10-01 Epub Date: 2023-11-04 DOI: 10.1177/00033197231213679

Konstantinos Tigkiropoulos, Katerina Sidiropoulou, Manolis Abatzis-Papadopoulos, Ioannis Lazaridis, Nikolaos Saratzis

{"title":"12-Month Outcomes of Carotid Artery Stenting With CGuard MicroNET-Covered Stent: A Single-Center Study in 113 Patients.","authors":"Konstantinos Tigkiropoulos, Katerina Sidiropoulou, Manolis Abatzis-Papadopoulos, Ioannis Lazaridis, Nikolaos Saratzis","doi":"10.1177/00033197231213679","DOIUrl":"10.1177/00033197231213679","url":null,"abstract":"Dual layer mesh stents constitute a novel treatment option for patients who undergo carotid artery stenting (CAS). The aim of this prospective study is to report 12 month outcomes of patients who underwent CAS with CGuard (Inspire MD, Tel Aviv, Israel) microNET self-expanding stent with embolic protection system in a tertiary center from October 2018 to March 2022. Primary endpoints included in-stent restenosis >70% verified by ultrasound (DUS), ipsilateral transient ischemic attack (TIA), and stroke at 12 months. Secondary endpoints included cardiovascular-related mortality (stroke, myocardial infarction, heart failure) and all-cause mortality during follow-up. One hundred thirteen patients were included in the study (male 72.5%), symptomatic 47.8%. Median follow-up was 25 months (2-48). By 12 months, there was one in-stent occlusion that manifested as stroke (1/113, 0.8%) but no other forms of in-stent restenosis. Two patients experienced contralateral TIA (1.7%). CVRM was 3.5% (4 MI) and all-cause mortality was 6% at follow-up. This prospective study shows that CAS with CGuard MicroNET-covered stent is safe with minimal neurological adverse events at 12 months follow-up. Larger, and longer-term studies are necessary to define CGuard long-term safety and protection against carotid-related stroke.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"841-847"},"PeriodicalIF":2.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71477381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impact of Contrast-Associated Acute Kidney Injury on One-Year Outcomes in Very Elderly STEMI Patients: A Comment. 对比度相关急性肾损伤对极老年 STEMI 患者一年预后的影响：评论。

IF 2.2 3区医学

Angiology Pub Date : 2025-10-01 Epub Date: 2024-03-05 DOI: 10.1177/00033197241238400

Monica Verdoia, Andrea Rognoni

引用次数: 0

Anemia Status as a Novel Biomarker of Risk of Heart Failure in Patients With Coronary Heart Disease. 贫血状态作为冠心病患者心力衰竭风险的新生物标志物

IF 2.2 3区医学

Angiology Pub Date : 2025-10-01 Epub Date: 2023-09-08 DOI: 10.1177/00033197231201709

Ying Li, Jing-Zhi Qiu

引用次数: 0

Carotid Artery Stenosis as a Predictor for Stroke Following Transcatheter Aortic Valve Implantation. 颈动脉狭窄是经导管主动脉瓣植入术后脑卒中的预测因素。

IF 2.2 3区医学

Angiology Pub Date : 2025-10-01 Epub Date: 2024-03-13 DOI: 10.1177/00033197241239687

Leonard Taube, Atsushi Sugiura, Arthur Hartmann, Christian Schaefer, Marwan Hamiko, Sebastian Zimmer, Georg Nickenig, Nadjib Schahab

{"title":"Carotid Artery Stenosis as a Predictor for Stroke Following Transcatheter Aortic Valve Implantation.","authors":"Leonard Taube, Atsushi Sugiura, Arthur Hartmann, Christian Schaefer, Marwan Hamiko, Sebastian Zimmer, Georg Nickenig, Nadjib Schahab","doi":"10.1177/00033197241239687","DOIUrl":"10.1177/00033197241239687","url":null,"abstract":"Stroke remains a clinical risk in the long-term follow-up of patients after transcatheter aortic valve implantation (TAVI). We aimed to investigate the association between existing carotid artery stenosis (CS) and the risk of stroke after TAVI. The study participants were consecutive patients who underwent TAVI between 2008 and 2020 and were screened for CS at baseline and at the 30-day follow-up. Hemodynamically relevant CS was defined as a reduction of the carotid artery caliber by >50% in relation to the distal segment. The primary endpoint of this study was ischemic stroke or transient ischemic attack (TIA) within 30 days of TAVI. Stroke-related death was also assessed. Of the 1,537 patients included, 220 (14.3%) patients had CS ≥50%. Within 30 days following TAVI, 41 patients (2.7%) experienced an ischemic stroke or TIA, and seven had stroke-related death. The median time from TAVI to stroke/TIA was 3.0 days. Patients with CS ≥50% had a 2.56-fold increased risk of stroke/TIA after TAVI (95%CI: 1.29-5.10, P = .006). The association was consistent in the multivariable model after adjusting for sex, atrial fibrillation, and estimated glomerular filtration rate. Investigations are needed to mitigate the risk of stroke in patients with CS ≥50%.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"848-856"},"PeriodicalIF":2.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140118617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Letter: Sociodemographic/Environmental Determinants of Health Associated With Stroke and Mental Disorders. 信：与中风和精神障碍相关的社会人口/环境健康决定因素。

IF 2.2 3区医学

Angiology Pub Date : 2025-10-01 Epub Date: 2024-07-21 DOI: 10.1177/00033197241264948

Sotirios A Koupidis

引用次数: 0

The Neutrophil to Lymphocyte Ratio Modifies Lipoprotein (a)-Related Poor Prognosis in Patients After Percutaneous Coronary Intervention. 中性粒细胞与淋巴细胞比率可改变经皮冠状动脉介入术后患者与脂蛋白 (a) 相关的不良预后。

IF 2.2 3区医学

Angiology Pub Date : 2025-10-01 Epub Date: 2024-05-19 DOI: 10.1177/00033197241255414

Zhangyu Lin, Jining He, Chenxi Song, Rui Zhang, Sheng Yuan, Xiaohui Bian, Kefei Dou

{"title":"The Neutrophil to Lymphocyte Ratio Modifies Lipoprotein (a)-Related Poor Prognosis in Patients After Percutaneous Coronary Intervention.","authors":"Zhangyu Lin, Jining He, Chenxi Song, Rui Zhang, Sheng Yuan, Xiaohui Bian, Kefei Dou","doi":"10.1177/00033197241255414","DOIUrl":"10.1177/00033197241255414","url":null,"abstract":"Lipoprotein (a) [Lp(a)] could contribute to coronary artery disease (CAD) through proinflammatory effects. The neutrophil to lymphocyte ratio (NLR) is an inflammatory biomarker. We consecutively enrolled 7,922 CAD patients to investigate the synergistic association of Lp(a) and NLR with prognosis in patients undergoing percutaneous coronary intervention (PCI). NLR was calculated as the neutrophil count divided by the lymphocyte count. Cutoff for NLR was a median of 2.07. The threshold value was set at 30 mg/dL for Lp(a). The primary endpoint was major adverse cardiac events (MACEs), including all-cause mortality and myocardial infarction. During 2 years follow-up, 111 (1.40%) MACEs occurred. Lp(a) > 30 mg/dL was associated with an increased MACE risk in participants with NLR ≥2.07 [adjusted hazard ratio (HR), 1.84; 95% CI, 1.12-3.03], but not in participants with NLR <2.07 (adjusted HR, 0.74; 95% CI, 0.38-1.45) (Pinteraction = 0.021). Subgroup analysis demonstrated that the synergistic association of Lp(a) and NLR with prognosis was more pronounced in female patients (Pinteraction = 0.028). This study suggested that combining Lp(a) and NLR may be useful for risk stratification in CAD population.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"876-885"},"PeriodicalIF":2.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141065238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Assessing the Role of Bioelectrical Impedance Vector Analysis in Prognosis and Prevention of Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention. 评估生物电阻抗矢量分析在经皮冠状动脉介入术后对比度相关急性肾损伤的预后和预防中的作用。

IF 2.2 3区医学

Angiology Pub Date : 2025-10-01 Epub Date: 2024-06-20 DOI: 10.1177/00033197241263718

Jing Wang, Gaoliang Yan, Lei Wang, Chengchun Tang

{"title":"Assessing the Role of Bioelectrical Impedance Vector Analysis in Prognosis and Prevention of Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention.","authors":"Jing Wang, Gaoliang Yan, Lei Wang, Chengchun Tang","doi":"10.1177/00033197241263718","DOIUrl":"10.1177/00033197241263718","url":null,"abstract":"This study evaluated the impact of Bioelectrical Impedance Vector Analysis (BIVA)-guided hydration therapy on contrast-associated acute kidney injury (CA-AKI) in patients undergoing percutaneous coronary intervention (PCI). From April 2022 to January 2023, this prospective study at the Eastern General Hospital of the Chinese People's Liberation Army involved 902 adults with stable coronary artery disease (CAD) scheduled for PCI. BIVA measurements were performed pre-contrast, followed by a standard hydration regimen. The study focused on the development of CA-AKI and major adverse cardiovascular events (MACE, including all-cause death, nonfatal myocardial infarction, and target vessel revascularization) within 1 year post-PCI. Among the 902 patients (average age: 60.8 years, 65.2% men), CA-AKI post-PCI was observed in 10.8%. Those with CA-AKI had more comorbidities and higher baseline creatinine levels. The contrast volume-to-estimated Glomerular Filtration Rate (eGFR) ratio was higher in CA-AKI patients, with a significantly increased resistance/height ratio (R/H). High R/H values correlated with a greater risk of MACE and all-cause mortality within a year. The study underscores the importance of BIVA-guided hydration therapy and R/H ratio in predicting CA-AKI in PCI patients with stable CAD. Incorporating R/H ratio assessments may enhance pre-procedural risk assessment and improve long-term outcomes (P = .0017).","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"894-903"},"PeriodicalIF":2.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141431225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Angiology最新文献